Patents expiring in 2037

US 9598495

Use of semaphorin-4D binding molecules for treating neurodegenerative disorders

VACCINEX, INC. · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9598492

Human monoclonal antibodies specific for CD22

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9598370

Prolyl hydroxylase inhibitors and methods of use

Akebia Therapeutics, Inc. · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9597336

Therapy for treatment of chronic degenerative brain diseases and nervous system injury

The Regents of the University of California · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9598471

Bacteriocin with novel activity

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9596855

Small molecule inhibitors of biofilm formation and the novel use of previously identified compounds for inhibition of biofilm formation and applications for drug therapy and medical device coating

The Regents of the University of California · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9597353

Redox signaling gel formulation

Reoxcyn Discoveries Group, Inc. · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9598400

Substituted quinoline compounds and methods of use

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9598432

2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

Rigel Pharmaceuticals, Inc. · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 3144307

NEUE OXAZOL DERIVATEN ALS SYK KINASEHEMMER

AB SCIENCE [FR] · Granted Wed Mar 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Mar 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9604997

Peri-carbinols

Aldeyra Therapeutics, Inc. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603781

Skin cleaning kit

Coviden LP · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603806

Pharmaceutical compositions for the treatment of Helicobacter pylori

RedHill Biopharma Ltd. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603896

Peptide compounds and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603829

HSP90 inhibitors with modified toxicity

The Regents of the University of Colorado, a Body Corporate · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603945

Heparosan polymers and methods of making and using same for the enhancement of therapeutics

The Board of Regents of the University of Oklahoma · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603824

Compositions and methods for controlling infections

Regents of the University of Minnesota · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603895

Cyclosporin analogues for preventing or treating hepatitis C infection

Enanta Pharmaceuticals, Inc. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9605054

Composition and method for treating a tauopathy

Northwestern University · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9605057

Endotrophin neutralization and use thereof

The Board of Regents of the University of Texas System · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9605000

Spiro azetidine isoxazole derivatives and their use as SSTR antagonists

Takeda Pharmaceutical Company Limited · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9605044

Methods and compositions for modulating immune tolerance

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9605026

Hydrogen-bond surrogate peptides and peptidomimetics for p53 reactivation

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9606124

Methods of detecting and treating stem-cell containing solid tumors

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9604976

Antibacterial compounds

SPERO GYRASE, INC. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9605259

Compounds and methods for modulating protein expression

Ionis Pharmaceuticals, Inc. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9604907

Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics

The Regents of the University of California · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9604901

Process to prepare treprostinil, the active ingredient in Remodulin®

United Therapeutics Corporation · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9605042

Compositions and methods related to tauopathy

Regents of the University of Minnesota · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9605255

Oligonucleotides for making a change in the sequence of a target RNA molecule present in a living cell

ProQR Therapeutics II B.V. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9605055

Anti-CD100 antibodies and methods of using the same

VACCINEX, INC. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603906

Inhalable liquid formulations of DNase I

Protalix Ltd. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9605077

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

PRECISION BIOLOGICS, INC. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603853

Formulations of viloxazine

Supernus Pharmaceuticals, Inc. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9605013

Derivatives of hemin with antibacterial and antiviral activity

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9604944

Arylpiperazine derivatives and methods of utilizing same

REVIVA PHARMACEUTICALS, INC. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603820

Ornithine aminotransferase inhibition with GABA analogues for treatment of hepatocellular carcinoma

Northwestern University · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603922

Modulation of NKT cell activity with antigen-loaded CD1d molecules

VACCINEX, INC. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603949

Oligonucleotide-based probes for detection of bacterial nucleases

INTEGRATED DNA TECHNOLOGIES, INC. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603907

Dry powder formulations of dNase I

Protalix Ltd. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603796

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

The Regents of the University of California · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9603954

Methods for generating radioimmunoconjugates

Actinium Phamaceuticals, Inc. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9604973

Anti-cancer polyketide compounds

The Regents of the University of California · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9605263

Compositions for modulating C9ORF72 expression

Ionis Pharmaceuticals, Inc. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9610309

Liquid viral formulations

ONCOLYTICS BIOTECH INC. · Granted Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9611230

1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

PTC THERAPEUTICS, INC. · Granted Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9610352

Lyophilized viral formulations

ONCOLYTICS BIOTECH INC. · Granted Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9610261

Methods of treating Prader-Willi Syndrome

OVID THERAPEUTICS INC. · Granted Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)